Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
It's never too early to think about retirement. Learn when to start planning for your retirement and ensure financial stability.
26,408 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A new Harvard Law study analyzes whether a safety-focused mission can survive investor pressure as Anthropic prepares...
The June S&P 500 quarterly rebalance could see new entrants like Marvell Technology, Reddit, and a mortgage-focused s...
OpenAI has filed confidential IPO paperwork with the SEC, signaling a public listing could be on the horizon. The mov...
The Roundhill Bitcoin Covered Call ETF uses a synthetic options strategy to generate income from Bitcoin exposure wit...
A federal judge in Illinois denied CoStar's bid to join the Zillow-MRED-Compass dispute as an amicus. The ruling may ...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
An Oppenheimer analyst has floated a $10 trillion valuation for SpaceX within five years, anchored by Starlink's cash...
AMLP delivered a record May 2026 payout and a 14% trailing return, underscoring resilient midstream cash flow. Invest...
Short sellers now hold about 31% of SpaceX’s tradable float, a level that could ignite a volatile squeeze unless the ...
AI-driven datacenters are pushing power demands higher, forcing a rethink of power distribution. Analysts flag musash...
Tom Lee of Fundstrat says July could lift U.S. stocks as valuations normalize after June volatility, supported by eas...